February 23, 2018
Yesterday, Insys Therapeutics, Inc. (NASDAQ:INSY) CEO Saeed Motahari and CFO Andrew Long presented at the 2018 RBC Capital Markets Global Healthcare Conference in New York.
The company has released its presentation, and we've embedded it below for your review. For a .pdf copy, click here.
To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
Read more articles tagged:
2018 RBC Capital Markets Global Healthcare Confere
Facts You Need to Know About Cannabis
October 15, 2020
5 Products Every Vegan Needs When Traveling
October 6, 2020
Quintessential Californian Edible Recipes to Make...
October 2, 2020
How Does Smoking Cannabis Contribute to Your Socia...
April 8, 2020
Can You Strengthen Your Immune System With Cannabi...
50 Blue Chip Stocks Worth Less than Half as Much a...
September 19, 2018
5 of Today's Biggest Marijuana Stock Losers -...
September 10, 2018
5 of Today's Biggest Marijuana Stock Gainers -...
September 5, 2018
September 4, 2018
2 Cannabinoid Biotech Companies Presenting at the RBC Conference
February 20, 2018
INSYS Therapeutics Adds Two New Executives to Senior Management Team
January 30, 2018
INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference
January 3, 2018
INSYS Therapeutics Initiates Phase 2 Clinical Trial of CBD Oral Solution
December 19, 2017
FDA Accepts New Drug Application for INSY Buprenorphine Sublingual Spray
December 6, 2017
Insys Founder Arrested on Fraud Charges, Nasdaq Halts Shares
October 27, 2017